Can-Fite BioPharma Begins Safety Study of Piclidenoson in Dogs

Can-Fite BioPharma Begins Safety Study of Piclidenoson in Dogs

By Chris Wack Can-Fite BioPharma Ltd. said its veterinary development and commercialization partner Vetbiolix, a France-based veterinary biotech company,

News story posted on 2021-11-23T12:44:00.0000000Z

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.